| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Malaria Consortium | |||||||||||||||
2 | Overall for Nigeria grant | Nigeria | Nigeria | Nigeria | Nigeria | Nigeria | Nigeria | Nigeria | Nigeria | |||||||
3 | Main calculations | Bauchi | FCT (Abuja) | Kebbi | Kogi | Nasarawa | Oyo | Plateau | Sokoto | |||||||
4 | Costs | |||||||||||||||
5 | ||||||||||||||||
6 | GiveWell costs | |||||||||||||||
7 | Donation size | $3,000 | - | - | - | - | - | - | - | - | ||||||
8 | Proportion of funding used in each state | 100% | 23% | 13% | 16% | 5% | 12% | 4% | 10% | 16% | ||||||
9 | Funding used in each state | - | $702 | $398 | $482 | $149 | $373 | $116 | $310 | $471 | ||||||
10 | ||||||||||||||||
11 | Cost per child covered | |||||||||||||||
12 | Upstream costs per SMC cycle administered after account for grantee-level adjustments | $1.37 | $1.37 | $1.37 | $1.37 | $1.37 | $1.37 | $1.37 | $1.37 | $1.37 | ||||||
13 | Number of SMC cycles per year | 4.4 | 4.0 | 5.0 | 4.0 | 5.0 | 5.0 | 5.0 | 5.0 | 4.0 | ||||||
14 | Upstream costs per child treated with all cycles of SMC in a year | - | $5.48 | $6.85 | $5.48 | $6.85 | $6.85 | $6.85 | $6.85 | $5.48 | ||||||
15 | ||||||||||||||||
16 | Outputs | |||||||||||||||
17 | ||||||||||||||||
18 | Total children covered | |||||||||||||||
19 | Total cycles of SMC administered with a $3,000 donation | 2,189 | 512 | 290 | 352 | 109 | 272 | 84 | 226 | 343 | ||||||
20 | ||||||||||||||||
21 | Total children covered | |||||||||||||||
22 | Total people under age 5 receiving a year of SMC with a $3,000 donation | 498 | 128 | 58 | 88 | 22 | 54 | 17 | 45 | 86 | ||||||
23 | ||||||||||||||||
24 | Outcomes | |||||||||||||||
25 | ||||||||||||||||
26 | Mortality reduction | |||||||||||||||
27 | Total malaria-attributable mortality rate (including direct and indirect malaria deaths) | - | 0.44% | 0.31% | 0.57% | 0.38% | 0.49% | 0.40% | 0.34% | 0.62% | ||||||
28 | Expected number of annual malaria-attributable mortalities among the treated population in the absence of SMC (children under 5) | 2.3 | 0.6 | 0.2 | 0.5 | 0.1 | 0.3 | 0.1 | 0.2 | 0.5 | ||||||
29 | Expected number of annual malaria-attributable mortalities among the untreated population in the absence of SMC (children over 5) | 1.7 | 0.2 | 0.3 | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 | ||||||
30 | Total annual malaria-attributable mortalities among children | 4.1 | 0.7 | 0.5 | 0.7 | 0.3 | 0.6 | 0.3 | 0.4 | 0.7 | ||||||
31 | Proportion of annual malaria mortality that occurs during the SMC season | - | 70% | 70% | 70% | 70% | 70% | 70% | 70% | 70% | ||||||
32 | Expected number of malaria-attributable mortalities among the target population during the SMC season in the absence of SMC | 2.9 | 0.5 | 0.3 | 0.5 | 0.2 | 0.4 | 0.2 | 0.2 | 0.5 | ||||||
33 | Expected reduction in malaria mortality among children under age 5 receiving SMC | - | 73% | 73% | 73% | 73% | 73% | 73% | 73% | 73% | ||||||
34 | Expected reduction in malaria mortality among older children in the protected population | - | 10% | 10% | 10% | 10% | 10% | 10% | 10% | 10% | ||||||
35 | Overall expected reduction in malaria mortality among children in the protected population | 46% | 59% | 35% | 52% | 29% | 40% | 25% | 37% | 59% | ||||||
36 | Total deaths averted among people under age 5 | 1.3 | 0.3 | 0.1 | 0.3 | 0.1 | 0.2 | 0.0 | 0.1 | 0.3 | ||||||
37 | ||||||||||||||||
38 | Adjustments | |||||||||||||||
39 | ||||||||||||||||
40 | Leverage and funging adjustment | - | -22% | -9% | -23% | -14% | -22% | -18% | -21% | -23% | ||||||
41 | ||||||||||||||||
42 | Counterfactual impact | |||||||||||||||
43 | ||||||||||||||||
44 | Counterfactual program outcomes | |||||||||||||||
45 | Total lives saved that wouldn't have been saved otherwise | 1.0 | 0.2 | 0.1 | 0.2 | 0.0 | 0.1 | 0.0 | 0.1 | 0.2 | ||||||
46 | ||||||||||||||||